These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 8550028)
21. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan. Suzuki Y; Kobayashi M; Ikeda K; Suzuki F; Arfase Y; Akuta N; Hosaka T; Saitoh S; Kobayashi M; Someya T; Matsuda M; Sato J; Watabiki S; Miyakawa Y; Kumada H J Med Virol; 2005 May; 76(1):33-9. PubMed ID: 15779048 [TBL] [Abstract][Full Text] [Related]
22. Long-term ganciclovir chemotherapy for congenital duck hepatitis B virus infection in vivo: effect on intrahepatic-viral DNA, RNA, and protein expression. Luscombe C; Pedersen J; Uren E; Locarnini S Hepatology; 1996 Oct; 24(4):766-73. PubMed ID: 8855174 [TBL] [Abstract][Full Text] [Related]
23. Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy. Hui CK; Cheung WW; Zhang HY; Au WY; Yueng YH; Leung AY; Leung N; Luk JM; Lie AK; Kwong YL; Liang R; Lau GK Gastroenterology; 2006 Jul; 131(1):59-68. PubMed ID: 16831590 [TBL] [Abstract][Full Text] [Related]
24. [Post-transplant prophylaxis of the recurrence of lamivudine-resistant YMDD mutant hepatitis B virus in liver recipients]. Yang Y; Yang Y; Zhang J; Yi HM; Lu MQ; Cai CJ; Li X; Jiang N; Xu C; Li H; Wang GS; Yi SH; Zhang JF; Jiang H; Yang Q; Chen GH Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1810-2. PubMed ID: 18971179 [TBL] [Abstract][Full Text] [Related]
25. Long-term ganciclovir therapy for hepatitis B virus infection after liver transplantation. Roche B; Samuel D; Gigou M; Feray C; Virot V; Majno P; Serraf L; David MF; Dusseaix E; Reynes M; Bismuth H J Hepatol; 1999 Oct; 31(4):584-92. PubMed ID: 10551379 [TBL] [Abstract][Full Text] [Related]
26. Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial. Mutchnick MG; Appelman HD; Chung HT; Aragona E; Gupta TP; Cummings GD; Waggoner JG; Hoofnagle JH; Shafritz DA Hepatology; 1991 Sep; 14(3):409-15. PubMed ID: 1874487 [TBL] [Abstract][Full Text] [Related]
27. Effectiveness of adenine arabinoside 5'-monophosphate in kidney transplant recipients with chronic active hepatitis B. Pol S; Saltiel C; Legendre C; Carnot F; Driss F; Berthelot P; Bréchot C; Ruet C; Kreis H Nephrol Dial Transplant; 1994; 9(7):820-3. PubMed ID: 7526277 [TBL] [Abstract][Full Text] [Related]
28. Effects of immunosuppressive therapy on hepatic expression of hepatitis B viral genome and gene products. Lau JY; Bird GL; Alexander GJ; Williams R Clin Invest Med; 1993 Jun; 16(3):226-36. PubMed ID: 8365050 [TBL] [Abstract][Full Text] [Related]
29. Oral ganciclovir treatment in chronic hepatitis B virus infection: a pilot study. Hadziyannis SJ; Manesis EK; Papakonstantinou A J Hepatol; 1999 Aug; 31(2):210-4. PubMed ID: 10453931 [TBL] [Abstract][Full Text] [Related]
30. Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro. McMillan JS; Shaw T; Angus PW; Locarnini SA Hepatology; 1995 Jul; 22(1):36-43. PubMed ID: 7601429 [TBL] [Abstract][Full Text] [Related]
31. Famciclovir treatment in transplant recipients with HBV-related liver disease: disappointing results. Berenguer M; Prieto M; Rayón M; Bustamante M; Carrasco D; Moya A; Pastor MA; Gobernado M; Mir J; Berenguer J Am J Gastroenterol; 2001 Feb; 96(2):526-33. PubMed ID: 11232701 [TBL] [Abstract][Full Text] [Related]
32. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. McKenzie R; Fried MW; Sallie R; Conjeevaram H; Di Bisceglie AM; Park Y; Savarese B; Kleiner D; Tsokos M; Luciano C N Engl J Med; 1995 Oct; 333(17):1099-105. PubMed ID: 7565947 [TBL] [Abstract][Full Text] [Related]
33. [The effects of nucleoside analogues on hepatitis B virus in hepatic lymph nodes of hepatitis B virus-associated liver transplantation recipients]. Chen Z; Zheng H; Shi R; Zheng WP; Chu ZQ; Song HL; Shen ZY Zhonghua Wai Ke Za Zhi; 2012 Sep; 50(9):835-8. PubMed ID: 23157962 [TBL] [Abstract][Full Text] [Related]
34. Combination antiviral therapy controls severe post-liver transplant recurrence of hepatitis B virus infection. Angus P; Richards M; Bowden S; Ireton J; Sinclair R; Jones R; Locarnini S J Gastroenterol Hepatol; 1993; 8(4):353-7. PubMed ID: 8374091 [TBL] [Abstract][Full Text] [Related]
35. Lack of sustained efficacy of combination ganciclovir and foscarnet for hepatitis B virus recurrence after liver transplantation. Singh N; Gayowski T Transplantation; 1995 Jun; 59(11):1629-30. PubMed ID: 7778181 [No Abstract] [Full Text] [Related]
36. Ganciclovir treatment of active hepatitis B virus infection in a heart transplant patient. Anand BS; Yoffe B; Young JB J Clin Gastroenterol; 1996 Mar; 22(2):144-6. PubMed ID: 8742657 [TBL] [Abstract][Full Text] [Related]
37. Focal segmental glomerulosclerosis as a complication of hepatitis B virus infection. Sakai K; Morito N; Usui J; Hagiwara M; Hiwatashi A; Fukuda K; Nanmoku T; Toda T; Matsui N; Nagata M; Yamagata K Nephrol Dial Transplant; 2011 Jan; 26(1):371-3. PubMed ID: 20959346 [TBL] [Abstract][Full Text] [Related]
38. Reactivated fulminant hepatitis B virus replication after bone marrow transplantation: clinical course and possible treatment with ganciclovir. Mertens T; Köck J; Hampl W; Schlicht HJ; Tillmann HL; Oldhafer KJ; Manns MP; Arnold R J Hepatol; 1996 Dec; 25(6):968-71. PubMed ID: 9007727 [TBL] [Abstract][Full Text] [Related]
39. [Hepatitis B and liver transplantation]. Fehérvári I; Görög D; Kóbori L; Varga M; Sárvári E; Gerlei Z; Nemes B Orv Hetil; 2007 Jul; 148(28):1299-302. PubMed ID: 17611179 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and Safety of Bortezomib in Multiple Myeloma Patients with Hepatitis B: A Multicenter Retrospective Study. Lu J; Chen WM; Geng CY; Durie BG; Huang XJ Chin Med J (Engl); 2016 Feb; 129(3):274-8. PubMed ID: 26831227 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]